Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Tianda Pharmaceuticals

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$34M
Portfolio companies 1
Rounds per year 0.03
Lead investments 0
Key employees Soon

Areas of investment

  • Pharmaceutical
  • Biotechnology
  • Medical

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Astorg France, Ile-de-France, Paris
Caitong Securities China, Hangzhou, Zhejiang
Coronis Medical Ventures California, Sunnyvale, United States
Future Money Seoul, Seoul-t'ukpyolsi, South Korea
GENTOSHA MediaConsulting Japan, Tokyo
Harbinger Capital Partners New York, New York, United States
InMotion Ventures England, London, United Kingdom
ION Crossover Partners Israel, Tel Aviv, Tel Aviv District
Razor Capital England, London, United Kingdom
Rocket Ventures Ohio, Toledo, United States
Rongxin Zhitong Beijing, Beijing Shi, China
Social Capital Hedosophia California, Palo Alto, United States
Source Interlink Companies Bonita Springs, Florida, United States
Tekelec International Morrisville, North Carolina, United States
United Finsec -
venture / science California, San Francisco, United States
Wuhan Optics Valley Elite Investment Management China, Hubei, Wuhan
Xinyu Tongrong Gongxing Touzi China, Jiangxi, Xinyu
Zhi Xin Qiye Guanli China, Shaanxi, Xian Shi

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ASLAN Pharmaceuticals

Biotechnology
Medical
Pharmaceutical
$34M07 Dec 2015 Singapore, Central Region, Singapore

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Tianda Pharmaceuticals?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 34M
Rounds per year 0.03
Peak activity year 2015
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

ASLAN Pharmaceuticals

Biotechnology
Medical
Pharmaceutical
$34M07 Dec 2015 Singapore, Central Region, Singapore
Crunchbase icon

Content report

The following text will be sent to our editors: